Adakah Perbedaan Kinerja Keuangan Perusahaan Farmasi Sebelum dan Selama Covid-19?

Annisa Lukman A. Gaffar (Mahasiswa Magister Manajemen STIEM Bongaya)
Rabihatun (Sekolah Tinggi Ilmu Ekonomi Makassar (STIEM) Bongaya)
La Ode Sumail (Sekolah Tinggi Ilmu Ekonomi Makassar (STIEM) Bongaya)

Jurnal Ekonomi
Vol. 27 No. 2 (2022): July 2022

The purpose of this research is to investigate whether there are significant differences in financial performance before Covid-19 and during Covid-19 in pharmaceutical companies listed on the IDX. The sample of this study was 9 companies and all of the population were sampled so that this study used the saturated sample technique. The analytical method used is a comparative test with a Paired T-test approach. The results of the study that ROE had a significant difference between before and during Covid-19 also had an impact on stock prices. Furthermore, the DPR has a significant difference between before and during Covid-19 so that it has an impact on stock prices. And lastly, PER has a significant difference between before and during Covid-19 which also has an impact on stock prices.